Documents/Guidances
1992 Anti-Infectives Points to Consider and also the IDSA/FDA guidances
Recent re-writes of guidance for various indications
Clinical Effectiveness Document
Again, focus here is on approved drugs with changes in dosing/formulation/combinations which lead to a NON-bioequivalent state